The contrast agent Isovue, according to its manufacturer, is said to be a safe and effective nonionic contrast medium ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
September 23, 2008 – In response to the FDA approval of Covidien’s ANDA for generic Kit for the Preparation of ...
September 24, 2008 - Philips Research and the University of Urbino (Urbino, Italy) this week signed a research agreement ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
September 22, 2008 – GE Healthcare said the FDA cleared AdreView (Iobenguane I 123 Injection), a molecular imaging agent ...
September 15, 2008 - Results from a safety study indicating that HX4, a new imaging biomarker that enables imaging ...
September 12, 2008 – Navilyst Medical launched two new devices this week, an enhanced PICC Convenience Kitting and a new ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
September 7, 2008 - Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection) by Lantheus Medical ...
September 4, 2008 - Cancer patients in Europe, and possibly worldwide, may face a longer wait for diagnostic tests and ...
August 22, 2008 - The 23rd Annual Advances in Contrast Ultrasound: Atherosclerosis Imaging and Interventions/Bubble ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
Bracco's Isovue (iopamidol injection) X-ray/CT contrast is reportedly a safe and effective nonionic contrast agent ...
August 18, 2008 – Maximus, a business unit of infusion therapy firm Medegen Inc., today announced as a result of a co ...
August 14, 2008 - Arlington Medical Resources (AMR), a provider of market intelligence for the pharmaceutical and ...
With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their ...
August 7, 2008 – MEDRAD Inc. completed today the first installation of its Intego PET Infusion System at the University ...
August 4, 2008 - There is no statistically significant difference between iopamidol-370 (Isovue-370) and iodixanol-320 ...
July 31, 2008 - Bristol-Myers Squibb Co. today offered $4.5 billion in cash for its cancer drug partner, ImClone Systems ...
July 29, 2008 – GE Healthcare reported results from a Phase I clinical trial of GE-067, a [18F]-labeled PET diagnostic ...
July 24, 2008 – Covidien recently launched the Optistar Elite contrast delivery system, designed to inject contrast ...
July 17, 2008 - GE Healthcare’s iodixanol, an isosmolar contrast medium, shows lower incidence of elevated serum ...
July 10, 2008 - A novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), has ...
The FDA approved Bayer HealthCare Pharmaceuticals’s EOVIST (Gadoxetate Disodium) Injection, a gadolinium-based contrast ...